These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 36036567)
1. Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho. MacLean MR; Fanburg B; Hill N; Lazarus HM; Pack TF; Palacios M; Penumatsa KC; Wring SA Compr Physiol; 2022 Aug; 12(4):4103-4118. PubMed ID: 36036567 [TBL] [Abstract][Full Text] [Related]
2. The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series). MacLean MMR Pulm Circ; 2018; 8(2):2045894018759125. PubMed ID: 29468941 [TBL] [Abstract][Full Text] [Related]
4. Serotonin and pulmonary hypertension--from bench to bedside? MacLean MR; Dempsie Y Curr Opin Pharmacol; 2009 Jun; 9(3):281-6. PubMed ID: 19286424 [TBL] [Abstract][Full Text] [Related]
5. [Serotonin hypothesis and pulmonary artery hypertension]. Kloza M; Baranowska-Kuczko M; Pędzińska-Betiuk A; Jackowski K; Kozłowska H Postepy Hig Med Dosw (Online); 2014 Jun; 68():738-48. PubMed ID: 24934532 [TBL] [Abstract][Full Text] [Related]
6. Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension. Dempsie Y; MacRitchie NA; White K; Morecroft I; Wright AF; Nilsen M; Loughlin L; Mair KM; MacLean MR Cardiovasc Res; 2013 Jul; 99(1):24-34. PubMed ID: 23519266 [TBL] [Abstract][Full Text] [Related]
7. The serotonin hypothesis of pulmonary hypertension revisited. Maclean MR; Dempsie Y Adv Exp Med Biol; 2010; 661():309-22. PubMed ID: 20204739 [TBL] [Abstract][Full Text] [Related]
8. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension. White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-361-3p suppresses serotonin-induced proliferation in human pulmonary artery smooth muscle cells by targeting SERT. Zhang Y; Chen Y; Chen G; Zhou Y; Yao H; Tan H Cell Mol Biol Lett; 2020; 25():45. PubMed ID: 33061998 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension and the serotonin hypothesis: where are we now? MacLean MR Int J Clin Pract Suppl; 2007 Sep; (156):27-31. PubMed ID: 17663674 [TBL] [Abstract][Full Text] [Related]
12. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Eddahibi S; Guignabert C; Barlier-Mur AM; Dewachter L; Fadel E; Dartevelle P; Humbert M; Simonneau G; Hanoun N; Saurini F; Hamon M; Adnot S Circulation; 2006 Apr; 113(15):1857-64. PubMed ID: 16606791 [TBL] [Abstract][Full Text] [Related]
13. Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH. White K; Loughlin L; Maqbool Z; Nilsen M; McClure J; Dempsie Y; Baker AH; MacLean MR Physiol Genomics; 2011 Apr; 43(8):417-37. PubMed ID: 21303932 [TBL] [Abstract][Full Text] [Related]
14. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension. Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140 [TBL] [Abstract][Full Text] [Related]
15. Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts. Mair KM; MacLean MR; Morecroft I; Dempsie Y; Palmer TM Br J Pharmacol; 2008 Oct; 155(4):606-16. PubMed ID: 18695640 [TBL] [Abstract][Full Text] [Related]
16. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice. Dempsie Y; Morecroft I; Welsh DJ; MacRitchie NA; Herold N; Loughlin L; Nilsen M; Peacock AJ; Harmar A; Bader M; MacLean MR Circulation; 2008 Jun; 117(22):2928-37. PubMed ID: 18506000 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension. Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719 [TBL] [Abstract][Full Text] [Related]
18. In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension. Morecroft I; Pang L; Baranowska M; Nilsen M; Loughlin L; Dempsie Y; Millet C; MacLean MR Cardiovasc Res; 2010 Feb; 85(3):593-603. PubMed ID: 19736308 [TBL] [Abstract][Full Text] [Related]
19. Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension. Aiello RJ; Bourassa PA; Zhang Q; Dubins J; Goldberg DR; De Lombaert S; Humbert M; Guignabert C; Cavasin MA; McKinsey TA; Paralkar V J Pharmacol Exp Ther; 2017 Feb; 360(2):267-279. PubMed ID: 27927914 [TBL] [Abstract][Full Text] [Related]
20. Serotonin inhibits apoptosis of pulmonary artery smooth muscle cell by pERK1/2 and PDK through 5-HT1B receptors and 5-HT transporters. Liu Y; Tian HY; Yan XL; Fan FL; Wang WP; Han JL; Zhang JB; Ma Q; Meng Y; Wei F Cardiovasc Pathol; 2013; 22(6):451-7. PubMed ID: 23601559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]